Papers
2
Total Citations
104
H-Index
2
About
Yinzhe Xu is a pioneering surgeon and researcher in robotic hepatopancreatobiliary (HPB) surgery, with a focus on advancing minimally invasive techniques for complex malignancies. His most influential work, a 2016 study on robotic radical resection for hilar cholangiocarcinoma, reported perioperative and long-term outcomes from an initial series, accumulating over 100 citations and establishing a benchmark for robotic approaches in this challenging disease. Xu’s contributions extend to evaluating next-generation robotic platforms, as demonstrated in his 2025 study on the Toumai® system, which detailed initial experience and technical considerations from a single center. This work highlights his role in integrating emerging technologies into clinical practice, potentially expanding access to robotic HPB surgery. With a career dedicated to improving surgical precision and patient outcomes, Xu’s research has shaped the adoption of robotics in hepatobiliary oncology. His findings continue to guide surgeons worldwide, offering evidence that robotic techniques can achieve oncologic efficacy while reducing invasiveness. Xu remains a key figure in the evolution of robotic surgery, bridging innovation and clinical application in high-stakes abdominal procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2